Product Details
Vilazodone hydrochloride is manufactured and marketed by Forest Pharmaceuticals (now part of Allergan/AbbVie) under the brand name Viibryd 2. The medication received FDA approval in 2011 for the treatment of major depressive disorder in adults 2, 3.
Available Formulations
Viibryd is available as film-coated tablets in three strengths 1:
- 10 mg tablets: Pink colored, ellipse shaped, biconvex, debossed with "MV" on one side and "14" on the other 1
- 20 mg tablets: Orange colored, ellipse shaped, biconvex, debossed with "MV" on one side and "15" on the other 1
- 40 mg tablets: Blue colored, ellipse shaped, biconvex, debossed with "MV" on one side and "16" on the other 1
Mechanism of Action
Vilazodone is classified as a dual-acting serotonergic agent that combines selective serotonin reuptake inhibitor (SSRI) properties with partial 5-HT1A receptor agonist activity 1, 2, 4. This multimodal mechanism distinguishes it from traditional SSRIs, though the clinical significance of the 5-HT1A partial agonism remains under investigation 5.